Both in Pharmaceuticals
Propanc Biopharma vs Oragenics
Over the past year PPCB returned −99.3% and OGEN returned −67.1%; their daily moves had a correlation of 0.09.
PPCB −99.3% OGEN −67.1%Growth of $1, one year, split-adjusted
| Metric | PPCB | OGEN |
|---|---|---|
| Price | $1.79 | $0.3720 |
| Market cap | $1.8M | $1.7M |
| Today | +4.68% | +0.51% |
| 1 month | −63.6% | −23.3% |
| 6 months | −92.9% | −40.0% |
| Year to date | −98.7% | −52.5% |
| 1 year | −99.4% | −69.5% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $832.0K | $3.9M |
| Dividend yield | — | — |
| Volatility (60d) | 730.0% | 50.3% |
| Short % of float | 0.7% | 24.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).